Kit For The Preparation Of Lymphoseek (technetium Tc 99m Tilmanocept) Kit
Product Images NDC 65857-425

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Kit For The Preparation Of Lymphoseek (technetium Tc 99m Tilmanocept) (NDC 65857-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 414, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
This is a description of a chromatography experiment. The text includes details about the solvent front line and midline, as well as the use of Biodex 150001 Red Strips and Whatman Grade 1, 3MM, 31ET Chromatography strips. There are measurements of distances provided in centimeters and millimeters. The experiment appears to be focused on separating and analyzing different types of molecules or compounds within a sample. *
FDA Label Image

Structural Formula (Image 02)

FDA Label Image

Principal Display Panel (Full Carton)

FDA Label Image

Principal Display Panel (Image 04)

Principal Display Panel (Image 04)
This is a kit for the preparation of Lymphoseek® injection, which contains Technetium Tc 99m Tilmanocept. Each vial contains 250 mcg of Tilmanocept powder. The contents include five vials of Tilmanocept powder, prescribing information, five Radioassay information shield labels, and twenty-five labels for product vials and individual syringes. The solution needs to be used within six hours after reconstitution and should be stored at controlled room temperature between 20°C-25°C with excursions permitted to 15°C to 30°C. This product is distributed by Cardinal Health 414, LLC in Dublin, OH, and is only available with a prescription.*
FDA Label Image

Principal Display Panel (Diluent Label)

Principal Display Panel (Diluent Label)
This is a description of a diluent for the medicine Lymphoseek. It is a non-pyrogenic, aqueous and contains 0.045 w/u Potassium Phosphate, 0.11% w/u Sodium Phosphate (Heptahydrate), 0.50% w Sodium Chloride and 0.40% wiv Phenol. It is stored at a controlled temperature of 20°C -25°C and should not be directly administered. The single-use vial should be discarded after use. This product is distributed by Cardinal Health 414, LLC. *

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.